Leukemia Specialists in Boston, MA

Daniel Deangelo, M.D.,PH.D.

Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School

Hematology

Eric Jacobsen, MD

Associate Professor of Medicine, Harvard Medical School; Clinical Director, Adult Lymphoma Program; Director, Histiocyte Disorders Center

Hematology

Kenneth Anderson, MD

Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

Oncology

Nancy Lin, MD

Professor of Medicine at Harvard Medical School, Dr. Lin’s research focuses on developing more effective therapies for patients with metastatic breast ca

Hematology

Vincent Ho, MD

Professor of Medicine, Harvard Medical School; Director of Clinical Operations, Stem Cell Transplantation, Dana-Farber Cancer Institute

Oncology

Joseph Antin, MD

Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus

Oncology

Jorge Castillo, MD

Associate Professor at Harvard Medical School, an Institute Physician at the Dana-Farber Cancer Institute, and the Clinical Director of the Bing Center for Waldenström M; Director of the WM-NET, a consortium composed of academic researchers in the United States focused on designing and executing clinical research in patients wi

Hematology

Robert Soiffer, MD

Chief of the Division of Hematologic Malignancies; Codirector of the Adult Stem Cell Transplantation Program; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology, Harvard Medical School

Oncology

Thomas Kupper, MD

Thomas B. Fitzpatrick Professor of Dermatology; Chair, Department of Dermatology, Brigham and Women's Hospital

Hematology

Judy Garber, M.D.

Chair and Chief of the Division of Cancer Genetics and Prevention at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School.&nb

Hematology

Arnold Freedman, MD

Professor of Medicine at Harvard Medical School, a member of Dana-Farber Cancer Institute's Department of Medical Oncology, and an attending physician at Brigh; Professor of Medicine, Harvard Medical School

Oncology

David Reardon, MD

Clinical Director, Center for Neuro-Oncology

Hematology

Andrew Brunner, M.D.

Hematology

Elisabeth Battinelli, M.D.

Associate Professor of Medicine, Harvard Medical School; Chief Resident, Medicine

Oncology

Jeremy Abramson, MD

Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma, Massachusetts General Hospital Cancer Center; Associate Professor of Medicine, Harvard Medical School

Oncology

Thomas Spitzer, MD

Professor of Medicine, Harvard Medical School; Director, Bone Marrow Transplant Program, Massachusetts General Hospital

Oncology

Tracy Batchelor, MD MPH

Hematology

Glenn Hanna, M.D.

Director of the Center for Cancer Therapeutic Innovation (CCTI), the early drug development program at DFCI. His clinical and translational research eff

Hematology

David Kuter, MD DPHIL

Director of Clinical Hematology at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School

Oncology

Amir Fathi, M.D.

Professor of Medicine, Harvard Medical School; Program Director, Center for Leukemia, Massachusetts General Hospital

Hematology